Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin vs Clindamycin vs Saline Lavage for Axillary Drainage
NCT02314806Phase 3Completed
- Sponsor
- Hospital General Universitario de Elche
- Start
- Jan 2013
- Primary completion
- Dec 2014
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
01
Overview
Phase 3, randomised trial of gentamicin and clindamycin in breast cancer, sponsored by Hospital General Universitario de Elche. Primary endpoint: Drainage volume discharge at 14 days. Started Jan 2013; status: completed.
02
Drugs
gentamicinclindamycin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02314806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314806.